Mercaptopurine Tablets(The Capital Medical University)

巯嘌呤微片(首都医科大学)

Report date: 2026/03/31 20:00:21

Base Information

Drug NameMercaptopurine Tablets(The Capital Medical University)
Drug Alias Name6-巯基嘌呤6巯基嘌呤巯嘌呤(2.2改良型)乐疾宁麦卡累金 +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxanthine-guanine phosphoribosyltransferase inhibitors
TargetsHypoxanthine-guanine phosphoribosyltransferase
Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A